PLG and Disseminated intravascular coagulation: In addition, dysregulated hemostasis in COVID-19-associated disseminated intravascular coagulation is exacerbated by an inhibition of fibrinolysis, indicating the plasminogen-plasmin-system as a potential target to prevent thromboembolic complications in COVID-19 patients [26].